Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 2/20 | 0.58 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.58 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.58 |
| ▸ | CDK2 | P24941 | 2/20 | 0.58 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.58 |
| ▸ | MPO | P05164 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | MGMT | P16455 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | DHFR | P00374 | 4/20 | 0.43 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3338311 | 0.83 | MGMT (0.68) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL7988070 | 0.81 | CDK2 (0.77) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL18072502 | 0.75 | NUDT1 (0.53) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL16852229 | 0.74 | MGMT (0.64) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL16464519 | 0.73 | CDK1 (0.40) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL16462904 | 0.73 | KMT2A (0.37) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL11699945 | 0.73 | CDK1 (0.54) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL16828192 | 0.72 | MGMT (0.54) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL5040455 | 0.72 | ADORA1 (0.60) | CDK1CCNB1CCNA2CDK2CCNA1 | |
| SCHEMBL16463635 | 0.72 | CCNA2 (0.41) | CDK1CCNB1CCNA2CDK2CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6303618-B1 | ADMINISTERING PURINE COMPOUND WHICH INHIBITS CYCLIC DEPENDENT KINASE ACTIVITY FOR THERAPY OF TUMOR OR OTHER CELL PROLIFERATION DISORDER | CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) | 2001-10-16 | — | — | US | disclosed |